In Veritas Stock Forward View
| IVMEDelisted Stock | USD 0.0007 0.00 0.00% |
IVME Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast In Veritas stock prices and determine the direction of In Veritas Medical's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of In Veritas' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the value of rsi of In Veritas' share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using In Veritas hype-based prediction, you can estimate the value of In Veritas Medical from the perspective of In Veritas response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of In Veritas Medical on the next trading day is expected to be 0.05 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.73. In Veritas after-hype prediction price | USD 8.75E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
IVME |
In Veritas Additional Predictive Modules
Most predictive techniques to examine IVME price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for IVME using various technical indicators. When you analyze IVME charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
In Veritas Naive Prediction Price Forecast For the 3rd of March
Given 90 days horizon, the Naive Prediction forecasted value of In Veritas Medical on the next trading day is expected to be 0.05 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.73.Please note that although there have been many attempts to predict IVME Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that In Veritas' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
In Veritas Stock Forecast Pattern
| Backtest In Veritas | In Veritas Price Prediction | Research Analysis |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of In Veritas stock data series using in forecasting. Note that when a statistical model is used to represent In Veritas stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.816 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0283 |
| MAPE | Mean absolute percentage error | 24.315 |
| SAE | Sum of the absolute errors | 1.7271 |
Predictive Modules for In Veritas
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as In Veritas Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.In Veritas After-Hype Price Density Analysis
As far as predicting the price of In Veritas at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in In Veritas or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of In Veritas, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
In Veritas Estimiated After-Hype Price Volatility
In the context of predicting In Veritas' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on In Veritas' historical news coverage. In Veritas' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered In Veritas' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
In Veritas is very steady at this time. Analysis and calculation of next after-hype price of In Veritas Medical is based on 3 months time horizon.
In Veritas Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as In Veritas is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading In Veritas backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with In Veritas, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 2 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0007 | 0.0009 | 25.00 |
|
In Veritas Hype Timeline
In Veritas Medical is currently traded for 0.0007. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. IVME is expected to increase in value after the next headline, with the price projected to jump to 8.75E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is forecasted to be 25.0%, whereas the daily expected return is currently at 0.0%. The volatility of related hype on In Veritas is about 0.0%, with the expected price after the next announcement by competition of 0.00. In Veritas Medical currently holds 1.21 M in liabilities. Note, when we think about In Veritas' use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next expected press release will be in a few days. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.In Veritas Related Hype Analysis
Having access to credible news sources related to In Veritas' direct competition is more important than ever and may enhance your ability to predict In Veritas' future price movements. Getting to know how In Veritas' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how In Veritas may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AAGC | All American Gld | 0.00 | 0 per month | 6.39 | 0.13 | 16.67 | (14.29) | 54.29 | |
| CHYL | China Senior Living | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 1,075 | |
| BISA | Baltic International USA | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 90.00 | |
| PLKT | Solar Gold | 0.00 | 5 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BFYW | Sauer Energy | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| INNX | Infinite Networks | 0.00 | 0 per month | 0.00 | 0.16 | 16.67 | 0.00 | 500.00 | |
| TKCI | TurnKey Capital | 0.00 | 0 per month | 0.00 | 0.05 | 0.00 | 0.00 | 136.31 | |
| ETNI | Entest Biomedical | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OCLG | Oncologix Tech | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CGSI | CGS International | 0.00 | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
In Veritas Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with In Veritas stock to make a market-neutral strategy. Peer analysis of In Veritas could also be used in its relative valuation, which is a method of valuing In Veritas by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
In Veritas Market Strength Events
Market strength indicators help investors to evaluate how In Veritas stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading In Veritas shares will generate the highest return on investment. By undertsting and applying In Veritas stock market strength indicators, traders can identify In Veritas Medical entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 7.0E-4 | |||
| Day Typical Price | 7.0E-4 |
In Veritas Risk Indicators
The analysis of In Veritas' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in In Veritas' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ivme stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.03 | |||
| Standard Deviation | 17.52 | |||
| Variance | 306.98 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for In Veritas
The number of cover stories for In Veritas depends on current market conditions and In Veritas' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that In Veritas is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about In Veritas' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in IVME Stock
If you are still planning to invest in In Veritas Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the In Veritas' history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance |